[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100413028":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":33,"locations":42,"responsibleParty":61,"collaborators":63,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":10,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":78,"maxAge":10,"enrollmentInfo":79,"targetDuration":10,"studyType":82,"phases":10,"briefSummary":83,"conditions":84,"keywords":86,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Insel Gruppe AG, University Hospital Bern","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Dry eye disease",null,"Patients with dry eye disease",[13,14],"Other: Ocular microbiome","Other: Ocular immune system",{"label":16,"type":10,"description":17,"interventionNames":18},"Healthy controls","Healthy controls without dry eye disease",[13,14],[20,24],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"Ocular microbiome","Taxonomical and functional characterization of the ocular microbiome",[9,16],{"type":6,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"Ocular immune system","Functional characterization of the tear fluid proteome, histology of conjunctival tissue and molecular assays",[9,16],[29],{"name":30,"affiliation":31,"role":32},"Martin Zinkernagel, Prof. Dr. Dr.","Department of Ophthalmology, Inselspital","PRINCIPAL_INVESTIGATOR",[34,38],{"name":30,"role":35,"phone":36,"phoneExt":10,"email":37},"CONTACT","+41 31 632 95 65","martin.zinkernagel@insel.ch",{"name":39,"role":35,"phone":40,"phoneExt":10,"email":41},"Denise Zysset, PhD","+41 31 632 85 10","denise.zysset@insel.ch",[43],{"facility":31,"status":44,"city":45,"state":10,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"RECRUITING","Bern","3010","Switzerland","CH",{"type":50,"coordinates":51},"Point",[52,53],7.44744,46.94809,{"lat":53,"lon":52},[56,57,58,59],{"name":30,"role":35,"phone":36,"phoneExt":10,"email":37},{"name":39,"role":35,"phone":40,"phoneExt":10,"email":41},{"name":30,"role":32,"phone":10,"phoneExt":10,"email":10},{"name":39,"role":60,"phone":10,"phoneExt":10,"email":10},"SUB_INVESTIGATOR",{"type":62,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[64,67],{"name":65,"class":66},"Stiftung OPOS","UNKNOWN",{"name":68,"class":66},"Fondation Bertarelli","100413028","ocular-microbiome-and-immune-system-in-dry-eyes-100413028",false,"NCT04658238","Ocular Microbiome and Immune System in Dry Eyes","Associations of the Ocular Microbiome and the Immune System in Dry Eye Disease","Inclusion Criteria:\n\n* Willing to sign informed consent\n* 18 years of age or older\n\nExclusion Criteria:\n\n* Not willing or able to sign informed consent\n* Younger than 18 years\n* Recent (3 month) history of use of systemic and\u002For topical antibiotics\n* Usage of medical eye drops (Lacrycon and other moisturizing eye drops are allowed)\n* Recent (3 month) history of ocular surgery",true,"ALL","18 Years",{"count":80,"type":81},600,"ESTIMATED","OBSERVATIONAL","The primary objectives of this study are the characterization of the ocular microbiome as well as of the local immune system in participants with and without dry eye disease. Secondary objectives are the identification of differences in the ocular microbiome as well as in the immune system between participants with and without dry eye disease to ultimately find associations between the ocular microbiome and the immune system in dry eye disease.",[85],"Dry Eye Disease",[87,88],"microbiome","immune system","2025-03-26",{"date":91,"type":92},"2025-04-01","ACTUAL",{"date":94,"type":92},"2020-10-01",{"date":96,"type":81},"2026-12-31",{"name":5,"class":6},1]